financetom
Business
financetom
/
Business
/
National Bank Reviews BMO's Q2 -- Cuts Target to $136, Maintains Outperform
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
National Bank Reviews BMO's Q2 -- Cuts Target to $136, Maintains Outperform
May 29, 2024 12:20 PM

02:52 PM EDT, 05/29/2024 (MT Newswires) -- BMO reported second-quarter adjusted EPS of $2.59 vs. NBF $2.69 and consensus $2.76.

Key Takeaways:

BMO reported a weak quarter, as expected, writes National Bank's Gabriel Dechaine. The main drag on the quarter was credit performance. PCLs were 30% above NBF forecast on the back of a 24% sequential increase in Gross Impaired Loans (GILs), the second big spike over the past three quarters. This forced the bank to re-set credit performance expectations, with BMO guiding to a similar level of loan losses delivered this quarter (i.e., 44bps total/41bps impaired) over the next few quarters.

"Assuming credit performance is maintained at these levels, and operational performance improves as it has since a disappointing Q1/24, we believe short-term stock upside potential is relatively attractive."

BMO is rated Outperform. Target cut to $136, from $143.

Price: 120.89, Change: -10.21, Percent Change: -7.79

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Dollar General May Miss First-Quarter Views, But Low Expectations Present Favorable Setup, UBS Says
Dollar General May Miss First-Quarter Views, But Low Expectations Present Favorable Setup, UBS Says
May 14, 2024
03:52 PM EDT, 05/14/2024 (MT Newswires) -- Dollar General ( DG ) may miss earnings and comparable sales expectations when it reports fiscal first-quarter results on May 30 but low expectations leading into the print offer a favorable setup, UBS Securities said on Tuesday. The brokerage reduced its earnings per share target to $1.50 from $1.55, putting it further below...
US FDA extends review of Ascendis Pharma's hormone disorder therapy
US FDA extends review of Ascendis Pharma's hormone disorder therapy
May 14, 2024
May 14 (Reuters) - The U.S. Food & Drug Administration has extended its review of Ascendis Pharma's ( ASND ) therapy to treat adult patients with a hormone disorder by three months, the company said on Tuesday. U.S.-listed shares of the company were down 6.6% in late afternoon trading. The health regulator notified that data submitted for the ongoing review...
MAG Silver Files Preliminary Base Shelf Prospectus; Reported Q1 Earnings Earlier Tuesday
MAG Silver Files Preliminary Base Shelf Prospectus; Reported Q1 Earnings Earlier Tuesday
May 14, 2024
03:58 PM EDT, 05/14/2024 (MT Newswires) -- MAG Silver ( MAG ) , which earlier Tuesday reported first-quarter results, said shortly before the close of trade said filed a preliminary short form base shelf prospectus. According to the latest statement, the filing is with the securities commissions in all of the provinces and territories of Canada. A corresponding registration statement...
Vistra Unusual Options Activity For May 14
Vistra Unusual Options Activity For May 14
May 14, 2024
Whales with a lot of money to spend have taken a noticeably bullish stance on Vistra ( VST ). Looking at options history for Vistra ( VST ) we detected 23 trades. If we consider the specifics of each trade, it is accurate to state that 52% of the investors opened trades with bullish expectations and 39% with bearish. From...
Copyright 2023-2026 - www.financetom.com All Rights Reserved